Lee's Pharmaceutical Holdings has a quick ratio of 0.71. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Lee's Pharmaceutical Holdings's Quick Ratio or its related term are showing as below:
FRA:L1PA'
s Quick Ratio Range Over the Past 10 Years
Min: 0.55 Med: 0.79 Max: 2.09
Current: 0.71
During the past 13 years, Lee's Pharmaceutical Holdings's highest Quick Ratio was 2.09. The lowest was 0.55. And the median was 0.79.
FRA:L1PA's Quick Ratio is ranked worse than 79.72% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs FRA:L1PA: 0.71
Lee's Pharmaceutical Holdings (FRA:L1PA) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Lee's Pharmaceutical Holdings Quick Ratio Related Terms
Lee's Pharmaceutical Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lee's Pharmaceutical Holdings Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Lee's Pharmaceutical Holdings's Quick Ratio falls into.
Lee's Pharmaceutical Holdings Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lee's Pharmaceutical Holdings (FRA:L1PA) has a Quick Ratio of 0.71 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Lee's Pharmaceutical Holdings and its competitors. This is 10% below median its historical median of 0.79. Over the past decade, Lee's Pharmaceutical Holdings' Quick Ratio has ranged from 0.55 to 2.09. According to the industry distribution chart, Lee's Pharmaceutical Holdings ranks #794 out of 996 companies in the Drug Manufacturers industry, placing it in the top 79.7%.
Is Lee's Pharmaceutical Holdings' Quick Ratio too high?
Lee's Pharmaceutical Holdings' current Quick Ratio of 0.71 is 10% below median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 2.09. The Drug Manufacturers industry median Quick Ratio is 1.45. Lee's Pharmaceutical Holdings' value of 0.71 is 51% below this industry median. Based on the distribution chart, Lee's Pharmaceutical Holdings ranks #794 out of 996 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Lee's Pharmaceutical Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Lee's Pharmaceutical Holdings' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Lee's Pharmaceutical Holdings ranks #794 out of 996 companies for Quick Ratio. This places Lee's Pharmaceutical Holdings in the lower half of its industry. The industry median Quick Ratio is 1.45. Lee's Pharmaceutical Holdings' value of 0.71 is 51% below this benchmark. Historically, Lee's Pharmaceutical Holdings' own Quick Ratio has ranged from 0.55 to 2.09 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 1.45, Lee's Pharmaceutical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lee's Pharmaceutical Holdings's current Quick Ratio of 0.71 is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Lee's Pharmaceutical Holdings and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lee's Pharmaceutical Holdings's current Quick Ratio is 0.71, which is 10% below median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lee's Pharmaceutical Holdings stock overvalued right now?
Lee's Pharmaceutical Holdings (FRA:L1PA) has a current Quick Ratio of 0.71. The stock's GF Value™ is €0.17, compared to a current price of €0.11 — trading 35.9% below its estimated fair value. The current Quick Ratio is 0.71, which is 10% below median its 10-year median of 0.79 and 51% below the Drug Manufacturers industry median of 1.45. Lee's Pharmaceutical Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Lee's Pharmaceutical Holdings (FRA:L1PA), the current Quick Ratio is 0.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lee's Pharmaceutical Holdings (FRA:L1PA) Overvalued in 2026?
Based on GuruFocus' analysis, Lee's Pharmaceutical Holdings stock appears to be undervalued.
The current stock price of €0.11 is trading 35.9% below its estimated GF Value™ of €0.17.
Key valuation signals for FRA:L1PA:
Quick Ratio: 0.71 (10% below median its 10-year median of 0.79)
GF Value™: €0.17 vs. price of €0.11 (35.9% below fair value)
Industry Position: 51% below the Drug Manufacturers median (#794 of 996)
No single metric tells the full story. See the FRA:L1PA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lee's Pharmaceutical Holdings Business Description
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
72GF Score
Get the complete analysis for FRA:L1PA
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L1PA has been successfully added to your 
